Correlation Between Viridian Therapeutics and Tracsis Plc

Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Tracsis Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Tracsis Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viridian Therapeutics and Tracsis Plc, you can compare the effects of market volatilities on Viridian Therapeutics and Tracsis Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Tracsis Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Tracsis Plc.

Diversification Opportunities for Viridian Therapeutics and Tracsis Plc

-0.45

Correlation Coefficient

Viridian Therapeutics  Tracsis Plc

Very good diversification

The 3 months correlation between Viridian and Tracsis is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Tracsis Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tracsis Plc and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Tracsis Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tracsis Plc has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Tracsis Plc go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Tracsis Plc

Assuming the 90 days trading horizon Viridian Therapeutics is expected to generate 1.51 times more return on investment than Tracsis Plc. However, Viridian Therapeutics is 1.51 times more volatile than Tracsis Plc. It trades about 0.14 of its potential returns per unit of risk. Tracsis Plc is currently generating about -0.08 per unit of risk. If you would invest  1,399  in Viridian Therapeutics on September 5, 2024 and sell it today you would earn a total of  636.00  from holding Viridian Therapeutics or generate 45.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Viridian Therapeutics  vs.  Tracsis Plc

Viridian Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Viridian Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Tracsis Plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tracsis Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Viridian Therapeutics and Tracsis Plc

The main advantage of trading using opposite Viridian Therapeutics and Tracsis Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Tracsis Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tracsis Plc will offset losses from the drop in Tracsis Plc's long position.

The idea behind Viridian Therapeutics and Tracsis Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.